Join us during RSNA 2023 for a Virtual Symposium, Current Practices in Breast MRI, sponsored by Bayer.
David Schacht, MD, MPH,
Associate Professor of
Radiology (Breast Imaging),
Northwestern University
Current Practices in Breast MRI
Date: November 28 | Time: 10:30 a.m. |
Hosted on the Microsoft Teams Platform
Breast MRI is continuing to evolve. Join David Schacht, MD, for an overview of the updated ACR guidelines on breast cancer screening for women with higher-than-average risk, which includes MRI as an option. Dr. Schacht will review data from literature that evaluates different MRI protocols for breast cancer screening and in previously treated breast cancer patients.
Dr. Schacht is a paid consultant of Bayer.
Key takeaways from this session will include:
- MRI is an important diagnostic tool for breast cancer.
- Breast MRI can be performed in 10-15 minutes in compliance with ACR Practice Parameters and ACR Accreditation Guidelines.
- ACR Appropriateness Criteria for Supplemental Breast Cancer Screening includes MRI with contrast, and shortened MRI with contrast protocols, as an option for supplemental screening in certain patients with higher risk of breast cancer
Any individuals depicted on this web page are actors and not actual health care providers or patients.
Patient Information listed on the Graphical User Interfaces are fictitious examples only and do not contain any actual patient data.
MRI images throughout this website are actual patient cases but all personal identifiers have been removed or otherwise anonymized. No personally identifiable information is shown.
You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
© 2020-2023 Bayer
BAYER, the Bayer Cross, MEDRAD Stellant, MEDRAD MRXperion, MEDRAD Stellant FLEX, MEDRAD XDS, MEDRAD Veris, MEDRAD Stellant P3T, MEDRAD Spectris Solaris, MEDRAD Spectris, MEDRAD Mark 7 Arterion, MEDRAD Mark V ProVis, MEDRAD Intego, MEDRAD Avanta, MEDRAD Twist & Go, MEDRAD VFlow, Certegra P3T, MEDRAD FluiDots, MEDRAD Vistron, MEDRAD Envision, MEDRAD Certo, MEDRAD, Stellant, MRXperion, Stellant FLEX, Veris, Spectris Solaris, Spectris, Mark 7 Arterion, Mark V ProVis, Avanta, Envision, Twist & Go, VFlow, Radimetrics, Certegra, P3T, Seamlessly Smart, DirectCARE, PartnerCARE, VirtualCare, SelectCARE, TechCARE and Calantic are trademarks owned by and/or registered to Bayer in the U.S. and/or other countries.
Bayer HealthCare LLC 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981
Last update: December 2023
